These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31365943)
21. Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer. Lee JH; Oh YM; Lee SD; Lee JS J Korean Med Sci; 2019 Jun; 34(21):e160. PubMed ID: 31144482 [TBL] [Abstract][Full Text] [Related]
22. Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. Spyropoulos AC; Lipardi C; Xu J; Lu W; Suh E; Yuan Z; Levitan B; Sugarmann C; De Sanctis Y; Spiro TE; Barnathan ES; Raskob GE Clin Appl Thromb Hemost; 2019; 25():1076029619886022. PubMed ID: 31746218 [TBL] [Abstract][Full Text] [Related]
23. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor. Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state. Coleman CI; Turpie AGG; Bunz TJ; Baker WL; Beyer-Westendorf J Thromb Res; 2018 Mar; 163():132-137. PubMed ID: 29407625 [TBL] [Abstract][Full Text] [Related]
25. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty. Suen K; Westh RN; Churilov L; Hardidge AJ J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244 [TBL] [Abstract][Full Text] [Related]
26. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism. Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411 [TBL] [Abstract][Full Text] [Related]
28. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial. Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR; Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682 [TBL] [Abstract][Full Text] [Related]
29. Aspirin versus rivaroxaban in postoperative bleeding after total knee arthroplasty: a retrospective case-matched study. Yuenyongviwat V; Tuntarattanapong P; Chuaychoosakoon C; Iemsaengchairat C; Iamthanaporn K; Hongnaparak T Eur J Orthop Surg Traumatol; 2019 May; 29(4):877-881. PubMed ID: 30627921 [TBL] [Abstract][Full Text] [Related]
30. Risk of recurrent venous thromboembolism according to baseline risk factor profiles. Prins MH; Lensing AWA; Prandoni P; Wells PS; Verhamme P; Beyer-Westendorf J; Bauersachs R; Bounameaux H; Brighton TA; Cohen AT; Davidson BL; Decousus H; Kakkar AK; van Bellen B; Pap AF; Homering M; Tamm M; Weitz JI Blood Adv; 2018 Apr; 2(7):788-796. PubMed ID: 29632234 [TBL] [Abstract][Full Text] [Related]
31. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials. Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475 [TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis. Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564 [TBL] [Abstract][Full Text] [Related]
34. [EINSTEIN CHOICE: Comparison of rivaroxaban treatment and prophylactic doses with aspirin in the extended treatment of patients with venous thromboembolism]. Kaymaz C Turk Kardiyol Dern Ars; 2017 Sep; 45(Suppl 4):1-7. PubMed ID: 28947723 [TBL] [Abstract][Full Text] [Related]
35. Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study. Sindet-Pedersen C; Staerk L; Pallisgaard JL; Gerds TA; Berger JS; Torp-Pedersen C; Gislason GH; Olesen JB Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):220-227. PubMed ID: 29945162 [TBL] [Abstract][Full Text] [Related]
36. [Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty]. Miao SG; Zhang XG; Lu JH; Yang Y; Lu N Zhongguo Gu Shang; 2015 Oct; 28(10):893-6. PubMed ID: 26727779 [TBL] [Abstract][Full Text] [Related]
37. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin. Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism. Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J J Thromb Thrombolysis; 2018 Oct; 46(3):339-345. PubMed ID: 29881958 [TBL] [Abstract][Full Text] [Related]
39. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes. Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307 [TBL] [Abstract][Full Text] [Related]
40. Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study. Lim MS; Indran T; Cummins A; Bennett A; Wood E; Brown S; McQuilten Z; Tran H; Epi MC; Chan NC; Chunilal S Semin Thromb Hemost; 2019 Mar; 45(2):187-195. PubMed ID: 30566971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]